2021 Annual Meeting | N6 - Neuroscience in the Clinic: Multimodal Tools for Cardiac Arrest Neuroprognostication

Date Wednesday 04/21/21

Time 05:00 PM - 07:00 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Neuroscience in the Clinic Session

Director(s) H. E. Hinson, MD, MCR, FAAN, Martinson K. Arnan, MD, FAAN

Topic(s) Epilepsy/Clinical Neurophysiology (EEG)

Learning Objectives Participants will become familiar with established and emerging biomarkers and tools for cardiac arrest prognostication and integrate this knowledge into their personal approaches for predicting post-arrest outcomes.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
05:00 PM - 05:05 PM EDT	Introduction	Introduction Martinson K. Arnan, MD, FAAN
05:05 PM - 05:25 PM EDT	Speaker	Case Presentation Sachin Agarwal, MD, MPH
05:25 PM - 05:55 PM EDT	Speaker	Current Clinical Algorithms for Neurologists Approaching the Cardiac Arrest Patient Karen Hirsch, MD
05:55 PM - 06:00 PM EDT	Break	Break
06:00 PM - 06:10 PM EDT	Abstract	001 - Detailed EEG pattern and spectral analysis can prognosticate good and poor neurologic outcomes after cardiac arrest Kurt Y. Qing, MD, PhD
06:10 PM - 06:20 PM EDT	Abstract	002 - Prognostic performance of serum neuron specific enolase (NSE) in comatose cardiac arrest survivors: a multiple thresholds meta-analysis Merin John
06:20 PM - 06:30 PM EDT	Discussion	Discussion of Abstracts H. E. Hinson, MD, MCR, FAAN, Martinson K. Arnan, MD, FAAN, Sachin Agarwal, MD, MPH, Karen Hirsch, MD
06:30 PM - 06:45 PM EDT	Speaker	Follow up of Case Sachin Agarwal, MD, MPH
06:45 PM - 07:00 PM EDT	Q&A	Questions and Panel Discussion H. E. Hinson, MD, MCR, FAAN, Martinson K. Arnan, MD, FAAN, Sachin Agarwal, MD, MPH, Karen Hirsch, MD

Faculty Disclosures
H. E. Hinson, MD, MCR, FAAN	Dr. Hinson has received personal compensation in the range of $0-$499 for serving as a Consultant for Rapid AI. Dr. Hinson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Martinson K. Arnan, MD, FAAN	Dr. Arnan has nothing to disclose.
	No disclosure on file
Kartavya Sharma, MD	Dr. Sharma has nothing to disclose.
Nicholas D. Schiff, MD	Dr. Schiff has received publishing royalties from a publication relating to health care. Dr. Schiff has received personal compensation in the range of $500-$4,999 for serving as a study section member with NIH. Dr. Schiff has a non-compensated relationship as a Guidelines Panel Member with AAN that is relevant to AAN interests or activities.
Kurt Y. Qing, MD, PhD	Dr. Qing has nothing to disclose.
Merin John	Ms. John has nothing to disclose.
Gary S. Gronseth, MD, FAAN	Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with AAN.
Peter B. Forgacs, MD	Dr. Forgacs has received personal compensation for serving as an employee of OVID Therapeutics Inc. Dr. Forgacs has received stock or an ownership interest from OVID Therapeutics Inc.
Karen Hirsch, MD	Dr. Hirsch has nothing to disclose.
Sachin Agarwal, MD, MPH	Dr. Agarwal has nothing to disclose.

��ɫ��

��ɫ��